Pharmaceutical Packaging and Labeling

The contract involves the packaging and labeling of Diazepam Tablets to comply with Department of Defense traceability, marking, and shipping standards, requiring all labels to be block-printed and all documentation to include comprehensive EDI submissions. The work must adhere to strict military specifications for identification, serial numbering, and packaging integrity to ensure full supply chain visibility and accountability across the DoD logistics network. The subcontract is issued under the North American Industry Classification System code 325998, reflecting its classification as an other pharmaceutical product manufacturing activity, and is managed by the Defense Logistics Agency on behalf of the Department of Defense. Performance is expected to meet federal defense procurement protocols, with all labeling and documentation finalized to support secure, auditable distribution through military channels. The contract was posted on July 20, 2026, and is linked to the specific award record SPE2DX25D8022 with delivery order SPE2D926F7458, indicating its placement within an existing procurement framework designed for critical pharmaceutical supply continuity. No set-aside status or geographic limitations are specified, implying this is a competitive subcontract open to qualified industrial suppliers capable of satisfying DoD’s stringent pharmaceutical handling requirements.